Neophotonics corp (NPTN)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash flows from operating activities
Net income (loss)

-17,076

-43,637

-53,333

-205

3,668

-19,719

-34,339

-17,530

-14,754

-

-

Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization

-

-

-

-

-

-

-

-

-

-

13,574

Depreciation and amortization

30,788

31,105

28,350

22,400

22,875

23,403

20,381

18,716

-

-

-

Net income (loss)

-

-

-

-

-

-

-

-

-

3,271

-6,847

Depreciation and amortization

-

-

-

-

-

-

-

-

12,931

12,122

-

Goodwill impairment charges

-

-

-

-

-

-

-

-

13,106

0

0

Stock-based compensation expense

12,456

14,142

8,206

17,076

7,763

6,841

5,736

4,777

3,156

1,598

981

Deferred taxes

-287

-328

792

-668

-641

1,175

-469

221

-452

-32

-62

Adjustment to fair value of Rusnano payment derivative

-

-

-

-

141

-291

101

-

-

-

-

Amortization of investment, debt and other

-414

-438

-247

-159

-296

-86

-1,003

-585

-345

-

-

Loss (gain) on sale of assets and other write-offs

-

-

-

-

-

-

-

-

224

-178

114

Loss (gain) on foreign currency hedges

0

-2,220

2,104

-1,640

0

-

-

-

-

-

-

Adjustment to fair value of contingent consideration

-

-

-

-

-

-

1,026

-554

-1,287

-

-

Share of loss of an unconsolidated investee

-

-

-

-

-

-

-

-

-

-620

0

Gain on sale of an unconsolidated investee, net of direct cost

-

-

-

-

-

-

-

-

13,867

0

-

Gain on discontinued operations

-

-

-

-

-

-

-

750

-

-

-

Gain on discontinued operations

-

-

-

-

-

-

-

-

-

0

-

Gain on sale of an unconsolidated investee, net of direct cost

-

-

-

-

-

-

-

-

-

-

0

Allowance for doubtful accounts

-13

61

577

-382

640

-266

-253

312

535

388

726

Write-down of inventories

7,847

6,133

8,349

2,983

6,486

1,517

3,207

3,132

680

1,175

1,145

Loss (gain) on disposal of property and equipment

872

-1,322

1,746

-185

-394

-162

-710

-152

-

-

-

Amortization of operating lease right-of-use assets

1,774

0

0

-

-

-

-

-

-

-

-

Foreign currency remeasurement and other, net

-910

-3,944

2,583

-2,661

-2,992

-2,343

-667

-

-

-

-

Asset impairment charge

-

-

-

-

-

1,130

-

-

-

-

1,233

Issuance of common stock in exchange for research and development services

2,500

0

0

-

-

-

-

-

-

-

-

Asset impairment charges

0

0

324

0

368

-

-

-

-

-

-

Change in assets and liabilities:
Accounts receivable

-5,838

7,874

-13,166

-2,496

-2,529

13,269

-7,234

1,802

2,750

682

5,369

Inventories

2,891

-7,368

22,347

1,332

14,899

-4,990

10,458

11,828

8,508

5,958

-3,257

Prepaid expenses and other assets

-429

-8,162

11,409

11,184

1,691

5,912

1,795

199

-1,795

3,167

491

Accounts payable

-41

-1,411

-10,874

23,111

-4,692

979

7,712

-2,992

-452

6,648

832

Accrued and other liabilities

-5,269

5,838

6,452

218

6,175

484

5,382

-1,030

-3,212

-2,579

2,897

Net cash provided by operating activities

34,687

19,595

-32,767

53,836

26,138

-

-

-

-12,510

13,582

11,762

Net cash (used in) provided by operating activities

-

-

-

-

-

-451

4,511

-8,790

-

-

-

Cash flows from investing activities
Purchase of property, plant and equipment

9,532

14,867

47,409

51,693

16,837

11,027

19,566

12,738

11,677

15,744

4,162

Proceeds from sale of property, plant and equipment and other assets

2,242

32

21,809

179

245

9

92

-

-

-

-

Purchase of marketable securities

157

920

52,062

82,728

37,130

9,662

58,860

155,887

172,972

0

0

Proceeds from sale of marketable securities

0

5,000

52,272

63,841

18,103

9,634

53,847

104,258

113,909

0

0

Proceeds from maturity of marketable securities

0

750

6,458

23,148

4,000

9,448

50,358

40,935

4,623

0

0

Restricted cash payable related to asset sale

-

-

-

1,039

-

-

-

-

-

-

-

Change in restricted cash

-

-

-

-

-10,135

10,847

-561

-608

48

-353

1,770

Settlement of foreign currency hedges

0

1,776

-1,618

1,599

0

-

-

-

-

-

-

Proceeds from initial public offering of common stock, net of issuance costs

-

-

-

-

-

-

-

-

-

-2,441

0

Proceeds from issuance of preferred stock, net of issuance costs

-

-

-

-

-

-

-

-

-

5,978

8,867

Proceeds from (payments for) public stock offering, net of offering costs

-

-

-

-

-

-10

-

-

-

0

-

Proceeds from sale of an unconsolidated investee

-

-

-

-

-

-

-

-

21,288

0

-

Acquisition of noncontrolling interest in subsidiary

-

-

-

-

-

-

-

-

-

104

655

Purchase of shares of an unconsolidated investee

-

-

-

-

-

-

-

-

-

8,077

0

Proceeds received on sale of discontinued operations, net of tax

-

-

-

-

-

-

-

-

-

0

-

Net cash used in investing activities

-7,447

-11,781

-17,314

-47,813

-21,906

-

-

-

-83,863

-24,690

-6,037

Proceeds from sale of an unconsolidated investee

-

-

-

-

-

-

-

-

-

-

0

Proceeds received on sale of discontinued operations, net of tax

-

-

-

-

-

-

-

1,825

-

-1,118

550

Net cash used in investing activities

-

-

-

-

-

-13,945

13,304

-20,999

-

-

-

Cash flows from financing activities
Proceeds from exercise of stock options and issuance of stock under ESPP

3,846

5,614

4,893

6,587

2,717

2,571

3,370

2,070

1,204

-

-

Acquisition of businesses, net

-

-

-

-

422

1,500

13,128

-

38,986

0

0

Offering costs

46

0

0

-

-

-

-

-

-

-

-

Proceeds from issuance of stock under ESPP

-

-

-

-

-

-

-

-

-

-

0

Tax withholding on restricted stock units

733

954

998

615

727

387

565

-

-

-

-

Payments for public stock offering, net of offering costs

0

0

-117

-164

45,648

-

-

-

-

-

-

Proceeds from initial public offering of common stock, net of issuance costs

-

-

-

-

-

-

-

-

86,412

-

-

Proceeds from issuance of common stock, net of issuance costs

-

-

-

-

-

-

-

39,636

-

-

-

Repurchases of common stock

-

-

-

-

-

-

-

-

-

1

37

Proceeds from exercise of stock options and warrants

-

-

-

-

-

-

-

-

-

127

80

Proceeds from issuance of stock under ESPP

-

-

-

-

-

-

-

-

-

0

-

Proceeds from bank loans, net of debt issuance costs

5,000

34,305

112,834

95,200

80,256

18,089

26,443

-

28,000

13,728

26,455

Repayment of bank loans

18,084

63,040

68,492

96,119

94,032

18,423

24,110

5,000

14,214

23,373

31,539

Repayment of notes payable

4,774

3,732

11,639

18,007

25,498

22,090

22,166

28,601

28,157

28,246

19,159

Proceeds from issuance of notes payable

0

7,137

6,621

16,032

21,259

25,264

19,543

25,959

29,390

26,925

24,343

Repayment of finance lease liabilities

87

0

0

-

-

-

-

-

-

-

-

Proceeds from government grants

0

1,210

0

602

0

-

-

-

-

-

-

Payment of acquisition-related contingent consideration

-

-

-

-

-

1,985

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

3,029

2,515

34,064

-

-

-

Net cash used in financing activities

-14,878

-19,460

43,102

3,516

29,623

-

-

-

102,635

-7,303

9,010

Effect of exchange rates on cash, cash equivalents and restricted cash

-161

-680

1,958

-1,702

-

-

-

-

-

-

-

Net increase in cash, cash equivalents and restricted cash

12,201

-12,326

-5,021

7,837

-

-

-

-

-

-

-

Effect of exchange rates on cash and cash equivalents

-

-

-

-

-802

-2,699

-169

180

758

456

-56

Net increase (decrease) in cash and cash equivalents

-

-

-

-

33,053

-14,066

20,161

4,455

7,020

-17,955

14,679

Supplemental disclosure of cash flow information:
Cash paid for interest

278

1,600

732

263

-

-

-

-

-

-

-

Transfer of short-term investments to restricted investments

-

-

-

-

-

8,297

-

-

-

-

-

Net cash paid (received) for income taxes

1,289

-1,383

5,388

2,215

-

-

-

-

-

-

179

Cash paid for interest

-

-

-

-

878

1,176

837

571

368

728

924

Cash paid for income taxes

-

-

-

-

264

3,919

1,013

531

1,532

2,881

-

Supplemental disclosure of non-cash investing and financing activities:
Neo Russia penalty settlement

2,000

0

0

-

-

-

-

-

-

-

-

Debt interest rolled into principal

1,368

0

0

-

-

-

-

-

-

-

-

Government approved expenditures incurred after receipt of government funds

579

0

0

-

-

-

-

-

-

-

-

Restricted cash receipt and payable related to asset purchase agreement

-

-

-

-

0

-

-

-

-

-

-

Unpaid deferred offering costs

-

-

-

117

0

364

-

-

-

-

-

Decrease (increase) in unpaid property, plant and equipment

-374

8,548

6,072

-13,629

-396

-746

-1,397

-

-

-

-

Capital lease

0

362

0

0

-

-

-

-

-

-

-

Modification of bank loan with Comerica

-

-

-

-

15,786

-

-

-

-

-

-

Issuance of note to seller of acquired business

-

-

-

-

15,482

-

11,130

-

-

-

-

Transfer of restricted investments to short-term investments

-

-

-

-

8,296

-

-

-

-

-

-

Asset retirement obligation

0

0

2,146

0

0

-

-

-

-

-

-

Unpaid property, plant and equipment in accounts payable

-

-

-

-

-

-

-

2,551

-986

-727

268

Accretion of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

7

113

153

Conversion of preferred stock to common stock upon IPO

-

-

-

-

-

-

-

-

228,597

-

-

Conversion of preferred stock to common stock upon IPO

-

-

-

-

-

-

-

-

-

0

-

Conversion of preferred stock to common stock upon IPO

-

-

-

-

-

-

-

-

-

-

0